“COVID-19 accounts for nearly 10 percent of all lung transplants in the U.S., reflecting a major shift in transplant trends.

COVID-related lung transplants are particularly challenging due to severe lung damage and complex surgeries, leading to longer and more resource-intensive recoveries.

Lung transplant candidates with COVID-19 face similar survival rates to other lung transplant patients, but their aftercare involves a dramatic adjustment to lifelong medications and new health risks.”